Stock Research for BAYZF


Featured Broker: Ally Invest

Get the due diligence for another stock.


BAYZF Stock Chart & Research Data

The BAYZF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BAYZF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


BAYZF Due diligence Resources & Stock Charts

The BAYZF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BAYZF Detailed Price Forecast - CNN Money CNN View BAYZF Detailed Summary - Google Finance
Yahoo View BAYZF Detailed Summary - Yahoo! Finance Zacks View BAYZF Stock Research & Analysis -

Stock Analysis

TradeIdeas View BAYZF Trends & Analysis - Trade-Ideas Barrons View BAYZF Major Holders - Barrons
NASDAQ View BAYZF Call Transcripts - NASDAQ Seeking View BAYZF Breaking News & Analysis - Seeking Alpha
Spotlight View BAYZF Annual Report - OTC Report View BAYZF OTC Short Report -
TradeKing View BAYZF Fundamentals - TradeKing Charts View BAYZF SEC Filings - Bar Chart
WSJ View Historical Prices for BAYZF - The WSJ Morningstar View Performance/Total Return for BAYZF - Morningstar
MarketWatch View the Analyst Estimates for BAYZF - MarketWatch CNBC View the Earnings History for BAYZF - CNBC
StockMarketWatch View the BAYZF Earnings - StockMarketWatch MacroAxis View BAYZF Buy or Sell Recommendations - MacroAxis
Bullish View the BAYZF Bullish Patterns - American Bulls Short Pains View BAYZF Short Pain Metrics -

Social Media Mentions

StockTwits View BAYZF Stock Mentions - StockTwits PennyStocks View BAYZF Stock Mentions - PennyStockTweets
Twitter View BAYZF Stock Mentions - Twitter Invest Hub View BAYZF Investment Forum News - Investor Hub
Yahoo View BAYZF Stock Mentions - Yahoo! Message Board Seeking Alpha View BAYZF Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for BAYZF - Insider Cow View Insider Transactions for BAYZF - Insider Cow
CNBC View BAYZF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BAYZF - OTC Markets
Yahoo View Insider Transactions for BAYZF - Yahoo! Finance NASDAQ View Institutional Holdings for BAYZF - NASDAQ

Stock Charts

FinViz View BAYZF Stock Insight & Charts - StockCharts View BAYZF Investment Charts -
BarChart View BAYZF Stock Overview & Charts - BarChart Trading View View BAYZF User Generated Charts - Trading View

Latest Financial News for BAYZF

Brazil court denies Monsanto bid to halt seed licensing to bankrupt firm
Posted on Thursday October 18, 2018

A Brazilian appeals court denied a request this month by Monsanto's local unit to suspend licensing of its popular Intacta soy seed technology to privately owned seed maker Sementes Talismã, according to a ruling seen by Reuters. Monsanto sought to suspend the licensing of the genetically modified seed technology after Talismã filed for bankruptcy protection in January, one of the seed maker's lawyers, Daniel Amaral of DASA Advogados in São Paulo, said. "Monsanto sought to end the licensing contract to try and negotiate better terms in Talismã's ongoing financial restructuring," Amaral said.

Jurors: Don't throw out $289M weed killer cancer verdict
Posted on Monday October 15, 2018

SAN FRANCISCO (AP) — Jurors who found that agribusiness giant Monsanto's Roundup weed killer contributed to a school groundskeeper's cancer are urging a San Francisco judge not to throw out the bulk of their $289 million award in his favor, a newspaper reported Monday.

Bayer may outsource some drug research - works council
Posted on Monday October 15, 2018

Bayer's chief executive is considering farming out certain drug research activities to cut costs amid slower growth at its pharmaceuticals division, the German company's works council said on Monday. The works council cited CEO Werner Baumann as he spoke to staff at a gathering at the group's Leverkusen headquarters on Sept 28. "Werner Baumann spoke about the prospect of weaker growth at the pharmaceutical business and mentioned considerations that some expenditures on pharma research could be outsourced," the works council said in a statement.

Bayer Stock Is Battling Back Against Legal Worries
Posted on Friday October 12, 2018

The German health-care and chemical giant’s depressed shares have reflected the worst-case scenarios for its cancer-related challenges. Last week’s legal victory could be the first of several.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.